Bioscience

Heska acquires majority interest in Cuattro Veterinary USA

Heska acquires majority interest in Cuattro Veterinary USA

LOVELAND - Heska Corporation (Nasdaq: HSKA), a provider of veterinary diagnostic and specialty products, has acquired a 54.6 percent interest in Pekin, Ill.-based Cuattro Veterinary USA, the... Read More

By: Steve Tuesday February 26, 2013 0 comments Tags: Cuattro Veterinary, Fort Collins, Heska, Robert Grieve

NIH awards $1.5M to CSU researcher to study environmental influences on Parkinson's Disease

NIH awards $1.5M to CSU researcher to study environmental influences on Parkinson's Disease

FORT COLLINS - The National Institutes of Health has awarded a $1.5 million grant to a Colorado State University researcher to study environmental influences that contribute to Parkinson's... Read More

By: Steve Friday February 22, 2013 0 comments Tags: CSU, Fort Collins, NIH, Parkinson's Disease, Ron Tjalkens

BioTech Pharma Symposium set for Feb. 28

BioTech Pharma Symposium set for Feb. 28

DENVER - BioTech Pharma Symposium 2013 , a half-day event addressing how biopharmaceuticals and biologics are changing lives every day, will be held Feb. 28 in Denver. The symposium, hosted by... Read More

By: Steve Thursday February 21, 2013 0 comments Tags: Denver

CU and Orphan Technologies to collaborate on therapy to treat rare disease

CU and Orphan Technologies to collaborate on therapy to treat rare disease

AURORA - The University of Colorado has signed exclusive, worldwide licensing and collaboration agreements with Zurich, Switzerland-based Orphan Technologies Ltd. to develop an enzyme replacement... Read More

By: Steve Thursday February 21, 2013 0 comments Tags: Aurora, Jan Kraus, Josef Rosenberg, Orphan Technologies

Snoasis Medical gets approval for BioXclude distribution in South Korea

Snoasis Medical gets approval for BioXclude distribution in South Korea

DENVER - Snoasis Medical Inc . and South Korea-based Purgo Biologics announced the signing of an agreement to distribute Snoasis' BioXclude product in South Korea. Bioxclude received market... Read More

By: Steve Wednesday February 20, 2013 0 comments Tags: BioXclude, Denver, Robert Tofe, Snoasis Medical

St. Renatus begins final adult phase 3 clinical trial for needle-free anesthetic

St. Renatus begins final adult phase 3 clinical trial for needle-free anesthetic

FORT COLLINS - St. Renatus LLC will conduct the third and expected final Adult Phase 3 Clinical Test of its nasal mist anesthetic at three universities this month, the company announced in its... Read More

By: Steve Tuesday February 19, 2013 0 comments Tags: Fort Collins, nasal mist, St. Renatus

Rocky Mountain life science investor conference is Sept. 18-19

Rocky Mountain life science investor conference is Sept. 18-19

DENVER - The 2013 Rocky Mountain Life Science Investor and Partnering Conference is set for Sept. 18-19 in Denver. The conference, hosted by Colorado BioScience Association, offers emerging... Read More

By: Steve Monday February 18, 2013 0 comments Tags: Denver

Venaxis signs agreement with European distributor, gets first APPY1 order

Venaxis signs agreement with European distributor, gets first APPY1 order

CASTLE ROCK - Venaxis Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA approval for its blood-based appendicitis test, announced it has signed its first European... Read More

By: Steve Thursday February 14, 2013 0 comments Tags: APPY1, Castle Rock, Don Hurd, EMELCA Bioscience, Venaxis